Skip to main content
Device Global Header

Subscribe
or Renew

Advanced Search

This article is available to subscribers. Subscribe now. Already have an account? Sign in

PerspectiveFree Preview

Transforming Management of Opioid Use Disorder with Universal Treatment

List of authors.
  • Rahul Gupta, M.D., M.P.H., M.B.A.,
  • Rachel L. Levine, M.D.,
  • Javier A. Cepeda, Ph.D., M.P.H.,
  • and David R. Holtgrave, Ph.D.

Barriers at multiple levels impede the use of evidence-based medication for opioid use disorder. Actions by clinicians, health care systems, and policymakers could substantially expand treatment access.

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Disclosure forms provided by the authors are available at NEJM.org.

This article was published on September 21, 2022, at NEJM.org.

Author Affiliations

From the White House Office of National Drug Control Policy (R.G., J.A.C., D.R.H.) and the Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services (R.L.L.) — both in Washington, DC; and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore (J.A.C.).

Print Subscriber? Activate your online access.